Saccomano Nicholas A

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Saccomano Nicholas A's trades of Onkure Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
21.58
Quantity 187,264 -56.8%
Value US$4,041,756
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-22
PlS Planned sale
63,680 -3.4%
393.65
US$3,859,986 		63,680 -3.4% 393.65 US$3,859,986
2026-03-24 2026-03-23
S Sale
12,748 -5.5%
234.46
US$4,838,607 		12,748 -5.5% 234.46 US$4,838,607
2025-12-23 2025-12-22
PlS Planned sale
90,339 +6.0%
222.55
US$4,250,620 		90,339 +6.0% 222.55 US$4,250,620
2025-09-24 2025-09-22
S Sale
88 -2.4%
2.62
US$231 		88 -2.4% 2.62 US$231
2025-06-25 2025-06-23
S Sale
88 -2.4%
2.38
US$210 		88 -2.4% 2.38 US$210
2025-04-08 2025-04-07
S Sale
516 -12.3%
2.67
US$1,378 		516 -12.3% 2.67 US$1,378
2025-04-08 2025-04-04
S Sale
358 -7.9%
3.33
US$1,191 		358 -7.9% 3.33 US$1,191
2019-02-08 2019-02-07
PlS Planned sale
187,264 -56.8%
21.58
US$4,041,756 		187,264 -56.8% 21.58 US$4,041,756